Clinical Trials Directory

Trials / Conditions / Platelet Transfusion Refractoriness

Platelet Transfusion Refractoriness

7 registered clinical trials studyying Platelet Transfusion Refractoriness — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingStudy of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
NCT06792019
Keymed Biosciences Co.LtdPhase 1 / Phase 2
CompletedEfficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
NCT05832216
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 1
UnknownEfficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR
NCT05761457
The First Affiliated Hospital of Soochow UniversityN/A
RecruitingRituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
NCT06254560
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
CompletedPlatelet Transfusion Refractoriness
NCT05399693
Institut de cancérologie Strasbourg Europe—
UnknownSequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL
NCT04846439
The First Affiliated Hospital of Soochow UniversityPhase 1 / Phase 2
CompletedComplement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transf
NCT02858323
National Institutes of Health Clinical Center (CC)—